Loading
An trial of MB-105 run by March Biosciences Inc, not yet recruiting.
A Long-term Follow-up Study of Patients Who Received MB-105 is an interventional study registered as NCT07340814 by March Biosciences Inc, with 40 participants planned, started 2026-02-27. Conditions recorded: Any Patient Treated With MB-105. Interventions recorded: MB-105.
Shares MB-105, March Biosciences and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/